Table 1.

Baseline Characteristics of Patients with Hepatocellular Carcinoma

Variables	Before PSM			After PSM
	Surgery (n=217)	HAIC-Surgery (n=131)	p value	Surgery (n=213)	HAIC-Surgery (n=107)	SMD	p value
Gender			0.621			0.012	0.921
Male	188(86.6%)	111(84.7%)		184(86.4%)	92(86.0%)
Female	29(13.4%)	20(15.3%)		29(13.6%)	15(14.0%)
Age(years)			0.946			0.003	0.978
≥60	72(33.2%)	43(32.8%)		70(32.9%)	35(32.7%)
<60	145(66.8%)	88(67.2%)		143(67.1%)	72(67.3%)
Degree of tumor differentiation			0.256			0.163	0.431
High	13(6.0%)	3(2.3%)		13(6.1%)	3(2.8%)
Moderate	177(81.6%)	109(83.2%)		173(81.2%)	89(83.2%)
Low	27(12.4%)	19(14.5%)		27(12.7%)	15(14.0%)
CNLC			<0.0001			0.367	0.051
Ia	104(47.9%)	34(26.0%)		100(46.9%)	34(31.8%)
Ib	79(36.4%)	51(38.9%)		79(37.1%)	51(47.7%)
IIa	13(6.0%)	12(9.2%)		13(6.1%)	12(11.2%)
IIb	8(3.7%)	20(15.3%)		8(3.8%)	2(1.9%)
III	13(6.0%)	14(10.7%)		13(6.1%)	8(7.5%)
ALT(U/L)			0.623			0.007	0.954
>40	69((31.8%)	45(34.4%)		67(31.5%)	34(31.8%)
≤40	148(68.2%)	86(65.6%)		146(68.5%)	73(68.2%)
ALB(g/L)			0.128			0.234	0.066
≥35	212(97.7%)	123(93.9%)		209(98.1%)	100(93.5%)
<35	5(2.3%)	8(6.1%)		4(1.9%)	7(6.5%)
TBIL(μmol/L)			0.951			0.024	0.839
>17.1	32(14.7%)	19(14.5%)		32(15.0%)	17(15.9%)
≤17.1	185(85.3%)	112(85.5%)		181(85.0%)	90(84.1%)
AFP(ng/mL)			0.291			0.217	0.073
≤400	137(63.1%)	90(68.7%)		136(63.8%)	79(73.8%)
>400	80(36.9%)	41(31.3%)		77(36.2%)	28(26.2%)
HBsAg			0.783			0.092
Positive	190(87.6%)	116(88.5%)		187(87.8%)	97(90.7%)		0.445
Negative	27(12.4%)	15(11.5%)		26(12.2%)	10(9.3%)
Main tumor size(cm)			0.882			0.031	0.796
≥10	26(12.0%)	15(11.5%)		26(12.2%)	12(11.2%)
<10	191(88.0%)	116(88.5%)		187(87.8%)	95(88.8%)
Tumor number			<0.0001			0.029	1
≤3	212(97.7%)	107(81.7%)		208(97.7%)	104(97.2%)
>3	5(2.3%)	24(18.3%)		5(2.3%)	3(2.8%)